🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06753734
Enrolling by invitation Observational

Early Prediction of Gestational Diabetes in High-risk Women Based on Breath Metabolomics

NCT06753734 · tracked via the Priya Life Science China tracker
Sponsor
Tianjin Central Hospital of Gynecology Obstetrics
Phase
Observational
Started
2024-12-25
Last updated
2025-05-31

Condition(s) studied

Gestational Diabetes

Study summary

This study aim to develope novel breath markers of gestational diabetes through a prospective high-risk population cohort study and achieve early prediction of gestational diabetes based on an interpretable machine learning model.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
55 Years
Healthy volunteers
Accepted
Eligibility Criteria * 18-55 years old * 11-14 weeks of pregnancy * at least one risk factor for GDM * signed a written informed consent Exclusion Criteria: * Diabetes mellitus or abnormal glucose metabolism before pregnancy * Hyperemesis gravidarum (urine ketone positive)) * Thyroid dysfunction * Asthmatic patients * Hypertensive diseases that are difficult to control * Severe hepatic and renal insufficiency or severe electrolyte disturbance * Malignant tumor * Acute inflammation * lung disease * Patients with gastritis, duodenum and other digestive system diseases * Those with upper respiratory or oral problems who cannot cooperate with expiratory collection * smoker

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Tianjin Central Hospital of Gynecology Obstetrics Tianjin China

More Tianjin Central Hospital of Gynecology Obstetrics trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06753734 on ClinicalTrials.gov ↗ ← All trials in China